Seguici su acebook facebook Cerca nel sito:

Le ricerche di Gerona 2005

(13-10-14) Review article: fungal microbiota and digestive diseases.



Wang ZK1, Yang YS, Stefka AT, Sun G, Peng LH.
Author information

Abstract
BACKGROUND:
The role of the fungal microbiota in digestive diseases is poorly defined, but
is becoming better understood due to advances in metagenomics.
AIM:
To review the gastrointestinal fungal microbiota and its relationship with
digestive diseases.
METHODS:
Search of the literature using PubMed and MEDLINE databases. Subject headings
including 'fungal-bacterial interactions', 'mycotoxins', 'immunity to fungi',
'fungal infection', 'fungal microbiota', 'mycobiome' and 'digestive diseases'
were used.
RESULTS:
The fungal microbiota is an integral part of the gastrointestinal
microecosystem with up to 10(6) microorganisms per gram of faeces. Next-
generation sequencing of the fungal 18S rRNA gene has allowed better
characterisation of the gastrointestinal mycobiome. Numerous interactions
between fungi and bacteria and the complex immune response to gastrointestinal
commensal or pathogenic fungi all impact on the pathophysiology of inflammatory
bowel disease and other gastrointestinal inflammatory entities such as peptic
ulcers. Mycotoxins generated as fungal metabolites contribute to disturbances
of gastrointestinal barrier and immune functions and are associated with
chronic intestinal inflammatory conditions as well as hepatocellular and
oesophagogastric cancer. Systemic and gastrointestinal disease can also lead to
secondary fungal infections. Fungal genomic databases and methodologies need to
be further developed and will allow a much better understanding of the
diversity and function of the mycobiome in gastrointestinal inflammation,
tumourigenesis, liver cirrhosis and transplantation, and its alteration as a
consequence of antibiotic therapy and chemotherapy.
CONCLUSIONS:
The fungal microbiota and its metabolites impact gastrointestinal function and
contribute to the pathogenesis of digestive diseases. Further metagenomic
analyses of the gastrointestinal mycobiome in health and disease is needed.

Source: Aliment Pharmacol Ther. 2014 Apr;39(8):751-66. doi: 10.1111/apt.12665. Epub
2014 Feb 24.

News

  • (30-08-2018) The electronics in fluorescent bulbs and light emitting diodes (LED), rather than ultraviolet radiation, cause increased malignant melanoma incidence in indoor office workers and tanning bed users

    Leggi tutto

  • (30-08-2018) Mitocondri e peso forma

    Leggi tutto

  • (29-08-2018) Stroke now impacting younger patients as a result of the obesity epidemic; 4 in 10 are now aged 40-69

    Leggi tutto

  • (29-08-2018) Perdere peso non vuol dire perdere osso!

    Leggi tutto

  • (29-08-2018) Brain cholesterol: long secret life behind a barrier.

    Leggi tutto

  • (29-08-2018) Stile di vita sano? Si può, basta usare la fantasia

    Leggi tutto

  • (22-08-2018) Top 10 medical treatments that can make you SICKER than before you took them

    Leggi tutto

  • (22-08-2018) Meno ansia - C’è una associazione tra dieta e disturbi mentali?

    Leggi tutto

  • (22-08-2018) Dietary curcumin supplementation attenuates inflammation, hepatic injury and oxidative damage in a rat model of intra-uterine growth retardation.

    Leggi tutto

  • (22-08-2018) Dopo la gravidanza - Una dieta a basso indice glicemico se serve perdere peso

    Leggi tutto

  • (21-08-2018) Sleep Disturbances Can Be Prospectively Observed in Patients with an Inactive Inflammatory Bowel Disease.

    Leggi tutto

  • (21-08-2018) Anche i neo-papà soffrono della depressione post partum

    Leggi tutto


In evidenza

"L'informazione presente nel sito serve a migliorare, e non a sostituire, il rapporto medico-paziente."

Per coloro che hanno problemi di salute si consiglia di consultare sempre il proprio medico curante.

Informazioni utili